News
What to Expect After Brain Surgery for Cancer
For many people with brain cancer, surgery is a critical step,... Here goes the content ...
‘I Got My Life Back’: A Parkinson’s Patient on DBS
How Loud Noise May Affect Your Hearing, Balance, and Risk of Falls
Sylvester researchers present a phase I trial at ASCO combining immunotherapy and an oncolytic virus to treat neuroendocrine tumors. Avatrombopag shows strong results in preventing chemotherapy-induced thrombocytopenia, helping patients avoid treatment delays. A Sylvester study identifies genetic markers that may predict aggressive solitary fibrous tumors, encouraging personalized cancer treatment. AI analysis of bone marrow biopsies uncovers immune signals that may guide personalized multiple myeloma treatment decisions.
Sylvester Comprehensive Cancer Center Researcher Presents Phase 1 Trial for Neuroendocrine Tumors at ASCO
Oral Medication Proves Effective for Low Platelets Due to Chemotherapy
Genetic Pattern May Identify Which Solitary Fibrous Tumors are More Aggressive
From Biopsy Slide to Tailored Treatment: AI Analysis of Bone Marrow Images Could Improve Myeloma Care
